Cardioprotection encompasses a variety of strategies protecting the heart against
myocardial injury that occurs during and after inadequate blood supply to the heart during …

Perioperative cardioprotection aims to minimize the consequences of myocardial ischemia–
reperfusion injury. In isolated tissue and animal experiments, several treatments have been …

The aim of pharmacological conditioning is to protect the heart against myocardial ischemia-
reperfusion (I/R) injury and its consequences. There is extensive literature that reports a …

Cardiac surgery patients are now more risky in terms of age, comorbidities, and the need for
complex procedures. It brings about reperfusion injury, which leads to dysfunction and/or …

Ischemic heart disease is the major cause of morbidity and mortality in the Western world.
With the advancing age of the surgical population, anesthesiologists increasingly have to …

The mechanisms by which ischaemia reperfusion injury can be influenced have been the
subject of extensive research in the last decades. Early restoration of arterial blood flow and …

A comment on this article appears in" Back and forth from basic science to clinical
translation." Minerva Anestesiol. 2020 Aug; 86 (8): 890-891. A comment on this article …

Coronary heart disease (CHD) is the leading cause of death worldwide. Coronary artery
bypass graft (CABG) surgery remains the procedure of choice for coronary artery …

Preconditioning has been shown to reduce myocardial damage caused by ischaemia–
reperfusion injury peri‐operatively. Volatile anaesthetic agents have the potential to provide …

SINCE THE MID-1970s, one of the important topics of anesthesiological research has been
the exploration of potential beneficial effects of anesthetics agents, and more specifically the …